Postmenopausal therapy reduces catalase activity and attenuates cardiovascular risk

Arquivos Brasileiros de Cardiologia

Volumn 99, Issue 5, 2012, Pages 1008-1014

  Castanho, Vera S ^a   Nakamura, Rui Tsutomu ^a   Pinto Neto, Aarão M ^a   De Faria, Eliana Cotta ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cardiovascular diseases; Catalase; Postmenopause; Risk factors

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CATALASE; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; ESTROGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID PEROXIDE; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE; NITRATE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ADULT; ANTIOXIDANT ACTIVITY; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONAL THERAPY; HOT FLUSH; HUMAN; NIGHT SWEAT; OXIDATIVE STRESS; POSTMENOPAUSE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD PROTEINS; CARDIOVASCULAR DISEASES; CATALASE; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LIPIDS; MIDDLE AGED; OXIDATIVE STRESS; POSTMENOPAUSE; RISK FACTORS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 84870431086     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2012005000097     Document Type: Article

References (39)

1. Fridovich I. The biology of oxygen radicals. Science. 1978;201(4359):875-80.
2. Signorelli SS, Neri S, Sciacchitano S, Pino LD, Costa MP, Marchese G, et al. Behaviour of some indicators of oxidative stress in postmenopausal and fertile women. Maturitas. 2006;53(1):77-82.
3. Miquel J, Ramírez-Boscá A, Ramírez-Bosca JV, Alperi JD. Menopause: a review on the role of oxygen stress and favorable effects of dietary antioxidants. Arch Gerontol Geriatr. 2006;42(3):289-306.
4. Bednarek-Tupikowska G, Tworowska U, Jedrychowska I, Radomska B, Tupikowski K, Bidzinska-Speichert B, et al. Effects of oestradiol and oestroprogestin on erythrocyte antioxidative enzyme system activity in postmenopausal women. Clin Endocrinol (Oxf). 2006;64(4):463-8.
5. Hodis HN, St John JA, Xiang M, Cushman M, Lobo RA, Mack WJ. Inflammatory markers and progression of subclinical atherosclerosis in healthy postmenopausal women (from the Estrogen in the Prevention of Atherosclerosis Trial). Am J Cardiol. 2008;101(8):1131-3.
6. Rosano GM, Vitale C, Fini M. Cardiovascular aspects of menopausal hormone replacement therapy. Climacteric. 2009;12(Suppl. 1):41-6.
7. Dick SE, DeWitt DE, Anawalt B. Postmenopausal hormone replacement therapy and mayor clinical outcomes: a focus on cardiovascular disease, osteoporosis, dementia and breast and endometrial neoplasia. Am J Manag Care. 2002;8(1):95-104.
8. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH, et al. The role of carotid arterial intimae-media thickness in predicting clinical coronary events. Ann Intern Med. 1998;128(4):262-9.
9. Karim R, Mack WJ, Lobo RA, Hwang J, Liu CR, Liu CH, et al. Determinants of the effects of estrogen on the progress of subclinical atherosclerosis: Estrogen in the Prevention of Atherosclerosis Trial. Menopause. 2005;12(4):357-78.
10. Somunkiran A, Yazici B, Demirci F, Erdogmus B, Ozdemir I. Effects of tibolone on blood flow resistance and intimae-media thickness of the carotid arteries: effect of time since menopause. Climacteric. 2006;9(1):59-65.
11. Hodis HN, Mack WJ. Atherosclerosis imaging methods: assessing cardiovascular disease and evaluating the role of estrogen in the prevention of atherosclerosis. Am J Cardiol. 2002;89(12A):19E-27E.
12. Berg GA, Siseles N, Gonzales AI, Ortiz OC, Tempone A, Wikinski RW. Higher values of hepatic lipase activity in post menopause: relationship with atherogenic intermediate density and low density lipoproteins. Menopause. 2001;8(1):51-7.
13. Herrera VM, Casas JP, Miranda JJ, Perel P, Pichardo R, Gonzalez A, et al. Interethnic differences in the accuracy of anthropometric indicators of obesity in screening for high risk of coronary heart disease. Int J Obes (Lond). 2009;33(5):568-76.
14. Tikkanen MJ, Nikkila EA, Kuusi T, Sipinen S. Effects of oestradiol and levonorgestrol on lipoprotein lipids and post-heparin plasma lipase activities in normolipoproteinemic women. Acta Endocrinol (Copenh). 1982;99(4):630-5.
15. Yatsuya H, Tamakoshi K, Hattori H, Otsuka R, Wada K, Zhang H, et al. Serum phospholipid transfer protein mass as a possible protective factor for coronary heart diseases. Circ J. 2004;68(1):11-6.
16. Ettinger B, Woods NF, Barrett-Connor E, Pressman A. The North American Menopause Society 1998 menopause survey: Part II. Counseling about hormone replacement therapy: association with socioeconomic status and access to medical care. Menopause. 2000;7(3):143-8.
17. Rosselli M, Imthurn B, Keller PJ, Jackson EK, Dubey RK. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol and norethisterone acetate: a two-year follow-up study. Hypertension. 1995;25(4 Pt 2):848-53.
18. Yagi K. Simple assay for the level of total lipid peroxides in serum or plasma. Methods Mol Biol. 1998;108:101-6.
19. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med. 1991;325(17):1196-204.
20. Inazu AJ, Koizumi J, Mabuchi H. Cholesteryl ester transfer protein and atherosclerosis. Curr Opin Lipidol. 2000;11(4):389-96.
21. Zhong S, Sharp DS, Grove JS, Bruce C, Yano K, Curb JD, et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest. 1996;97(12):2917-23.
22. Bhatnagar D, Durrington PN, Channon KM, Prais H, Mackness MI. Increased transfer of cholesteryl esters from high density lipoproteins to low density and very low density lipoproteins in patients with angiographic evidence of coronary artery disease. Atherosclerosis. 1993;98(1):25-32.
23. Sacks FM, Walsh BW. The effects of reproductive hormones on serum lipoproteins: unresolved issues in biology and clinical practice. Ann NY Acad Sci. 1990;592:272-85.
24. Hirano K, Yamashita S, Matsuzawa Y. Pros and cons of inhibiting cholesteryl ester transfer protein. Curr Opin Lipidol. 2000;11(6):589-96.
25. Bednarek-Tupikowska G, Tupikowski K, Bidzińska B, Bohdanowicz-Pawlak A, Antonowicz-Juchniewicz J, Kosowska B, et al. Serum lipid peroxides and total antioxidant status in postmenopausal women on hormone replacement therapy. Gynecol Endocrinol. 2004;19(2):57-63.
26. Kesim MD, Aydin Y, Erdemir M, Atis A. Nitric oxide in postmenopausal women taking three different HT regimens. Maturitas. 2005;50(1):52-7.
27. White RE, Gerrity R, Barman SA, Han G. Estrogen and oxidative stress: a novel mechanism that may increase the risk for cardiovascular disease in women. Steroids. 2010;75(11):788-93.
28. Salhotra S, Arora S, Anubhuti, Trivedi SS, Bhattacharjee J. Influence of menopause on biochemical markers of endothelial dysfunction-A case-control pilot study in North Indian population. Maturitas. 2009;62(2):166-70.
29. Baud O, Greene AE, Li J, Wang H, Volpe JJ, Rosenberg PA. Glutathione peroxidase-catalase cooperativity is required for resistence to hydrogen peroxide by mature rat oligodendrocytes. J Neurosci. 2004;24(7):1531-40.
30. Cotgreave I, Moldedeus P, Orrenius S. Host biochemical defense mechanisms against prooxidants. Annu Rev Pharmacol Toxicol. 1988;28:189-212.
31. Cagnacci A, Tarquini R, Perfetto F, Arangino S, Zanni AL, Cagnacci P, et al. Endothelin-1 and nitric oxide levels are related to cardiovascular risk factors but are not modified by estradiol replacement in healthy postmenopausal women. A cross-sectional and a randomized cross-over study. Maturitas. 2003;44(2):117-24.
32. Park E, Kyoung Park Y, Kim SM, Lee HJ, Kang MH. Susceptibility to oxidative stress is greater in Korean Patients with Coronary Artery Disease than Healthy Subjects. J Clin Biochem Nutr. 2009;45(3):341-6.
33. Borras C, Gambini J, Gomez-Cabrera MC, Sastre J, Pallardó FV, Mann GE, et al. 7 Beta-oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/ NFkappaB cascade. Aging Cel. 2005;4(3):113-8.
34. Mittal PC, Kant R. Role of free radicals in menopausal distress. J Clin Diagn Res. 2009;3:1900-2.
35. Abbas AM, Elsamanoudy AZ. Effects of 17β-estradiol and antioxidant administration on oxidative stress and insulin resistance in ovariectomized rats. Can J Physiol Pharmacol. 2011;89(7):497-504.
36. Dabrosin C, Hammar M, Ollinger K. Impact of oestradiol and progesterone on antioxidant activity in normal human breast epithelial cells in culture. Free Radic Res. 1998;28(3):241-9.
37. Mobley JA, Bruegggemeler RW. Estrogen receptor-mediated regulation of oxidative stress and damage in breast cancer. Carcinogenisis. 2004;25(1):3-9.
38. Ahn J, Nowell S, McCann SE, Yu J, Carter L, Lang NP, et al. Associations between catalase phenotype and genotype: modification by epidemiologic factors. Cancer Epidemiol Biomarkers Prev. 2006;15(6):1217-22.
39. Escalante Gómez C, Quesada Mora S. HRT decreases DNA and lipid oxidation in postmenopausal women. Climacteric. 2012 Apr 24 [Epub ahead of print].